May 23, 2017 by CDR Blog and Chain Drug Review
Adam Fein, Amazon, Drug Channels, Drug Channels Institute, online retailing
CDR Blog
Amazon’s success as a pioneer of online retailing is unquestioned, and it continues to be a disruptor to brick-and-mortar retailers (most recently, grocery retailers). But the e-tail giant’s alternatives in the pharmacy space — which CNBC reported it has targeted — aren’t so clear cut, according to pharmacy supply chain expert Adam Fein. “I would
May 17, 2017 by CDR Blog and Chain Drug Review
Amazon, drugstore.com, Mark Lyons, Rite Aid
CDR Blog
Amazon’s move into groceries shook up the food retail scene. That scenario may be in store for pharmacies. CNBC reported Tuesday evening that Amazon is ushering in a “business lead” to explore a foray into the pharmacy business and that the company has stepped up recruiting from the pharmacy arena. Citing unidentified sources, CNBC said
May 16, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
CDR Blog, Leading Headlines
Walgreens Boots Alliance and Rite Aid last week said they’ve complied with the Federal Trade Commission’s second request for information on their merger deal. But it appears the FTC still wants to know more. The New York Post reported Tuesday that the FTC has issued civil investigative demands (CIDs) to Walgreens vendors and competitors to
May 10, 2017 by CDR Blog and Chain Drug Review
Health Mart, Osita Najomo, PrescriptN2U, SnapPrescriptN, Westlake Health & Beauty Products, Westlake Health Mart Pharmacy
CDR Blog
Westlake Health Mart Pharmacy in Forth Worth, Texas, understands what today’s pharmacy customer wants: convenience and digital access. The new Health Mart, serving the Dallas-Fort Worth area, has a brick-and-mortar location but describes itself as a “digital pharmacy” whose “main goal is to provide medications in a timely manner, creating a convenient and stress-free service
May 8, 2017 by CDR Blog and Chain Drug Review
Drug Supply Chain Security Act, DSCSA, Healthcare Distribution Alliance, importation of prescription drugs, John Gray, National Association of Chain Drug Stores, PDUFA, Prescription Drug User Fee Act, Steve Anderson, The Hill, U.S. pharmaceutical supply chain
CDR Blog
Efforts to promote the importation of prescription drugs — seen by some as one way to mitigate the escalating cost of medications — could compromise the safety of the U.S. pharmaceutical supply chain, according to HDA’s John Gray and NACDS’ Steve Anderson. In a blog post on Monday for the policy journal The Hill, Gray,
May 5, 2017 by CDR Blog and Chain Drug Review
American Health Care Act, Eric Hoskins, Justin Bates, Kathleen Wynne, Neighbourhood Pharmacy Association of Canada, OHIP+ Children and Youth Pharmacare, Ontario Pharmacists Association, Sean Simpson, universal pharmacare
CDR Blog
The push to repeal the Affordable Care Act is again under way, with the House this week passing the latest iteration of the G.O.P.’s American Health Care Act in a close vote. Coverage of essential health benefits and pre-existing conditions are among the key ACA benefits in the crosshairs. Worse, millions of Americans could end
April 26, 2017 by CDR Blog and Chain Drug Review
Albertsons, Amazon, Cerberus Capital Management, JANA Partners, Scott Mushkin, Sprouts Farmers Markets, Walgreens-Rite Aid merger, Whole Foods Markets, Wolfe Research
CDR Blog
Albertsons Cos. reportedly is eyeing Whole Foods Markets, but it appears such an acquisition would be difficult for the Boise-based food and drug retailer to swallow. The Financial Times reported this week that Cerberus Capital Management, which leads the investor group that owns Albertsons, has engaged in preliminary discussions with bankers about a possible bid
April 25, 2017 by CDR Blog and Chain Drug Review
B. Douglas Hoey, DrugBenefitSolutions, independent community pharmacies, Mark Merritt, National Community Pharmacists Association, NCPA, NCPA's Congressional Pharmacy Fly-In, PBMs, PCMA, Pharmaceutical Care Management Association, pharmacy benefit managers, The PBM Story
CDR Blog
A lobbying event in Washington has triggered salvoes between two combatants: independent community pharmacies and pharmacy benefit managers. The National Community Pharmacists Association is holding its Congressional Pharmacy Fly-In advocacy drive this week, where it will also release “The PBM Story: What They Say, What They Do, and What Can Be Done About It,” offered
April 19, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA-Rite Aid deal
CDR Blog
Rite Aid saw its stock price sink to a 52-week low on Wednesday after a report that the Federal Trade Commission may challenge the drug chain’s acquisition by larger rival Walgreens Boots Alliance. Citing trade publication The Capital Forum, Bloomberg reported that the FTC was mulling a lawsuit to block the deal. Rite Aid’s share
April 19, 2017 by CDR Blog and Chain Drug Review
eco-friendly products, environmentally friendly products, GfK MRI, GfK MRI's Survey of the American Consumer
CDR Blog
Though eco-friendly products tend to cost more, U.S. shoppers will shell out extra if it does some good for the environment. A poll by market researcher GfK MRI found that 56% of American consumers are willing to pay more to use environmentally friendly products, up from 53% in 2010. GfK MRI’s Survey of the American
April 18, 2017 by CDR Blog and Chain Drug Review
Amazon, BJ's Wholesale Club, CVC Capital Partners, Leonard Green & Partners, Whole Foods Market
CDR Blog
Amazon has sure fed the acquisition rumor mill recently. The latest scuttlebutt: The online retail giant is taking a look at BJ’s Wholesale Club. The New York Post has reported that privately held BJ’s is putting itself on the block after its ownership determined that an IPO was ill-timed. Citing anonymous sources, the Post article
April 5, 2017 by CDR Blog and Chain Drug Review
Canadian pharmacists, Canadian Pharmacists Association, Canadian Pharmacists Journal, Cost-Effectiveness of Pharmacist Care, full-scope pharmacist care, pharmacist care, pharmacy care, Phil Emberley
CDR Blog
A Canadian study has put a dollar figure on the impact that expanded pharmacy care could have in the larger realm of health care. The peer-reviewed research, “Cost-Effectiveness of Pharmacist Care for Managing Hypertension in Canada,” revealed that long-term pharmacist care for Canadians with hypertension — including patient education and prescribing — can improve health
March 31, 2017 by CDR Blog and Chain Drug Review
Federal Trade Commission, Fred's, Maureen Ohlhausen, Rite Aid, Sean Reyes, Walgreens Boots Alliance, Walgreens-Rite Aid merger
CDR Blog
Walgreens Boots Alliance has gone ahead and set a deadline for the Federal Trade Commission to approve its deal to acquire Rite Aid Corp. According to the New York Post, WBA has “certified compliance” in its application, meaning that it has provided the FTC with the information needed to determine if the Walgreens-Rite Aid merger
March 20, 2017 by CDR Blog and Chain Drug Review
Bruce Carlson, in-store clinics, Kalorama Information, retail clinic, retail health clinics
CDR Blog
In recent years, physician groups have knocked the growth of retail health clinics as an encroachment on their turf. But health care market researcher Kalorama Information says that’s not necessarily the case. Consumers who have visited a retail clinic in the past year are much more apt to have seen a physician in that time